Sharp John P 4
4 · PhaseBio Pharmaceuticals Inc · Filed May 24, 2021
Insider Transaction Report
Form 4
Sharp John P
CFO and Secretary
Transactions
- Award
Common Stock
2021-05-20$2.80/sh+1,419$3,973→ 42,724 total
Footnotes (1)
- [F1]These shares were acquired under the PhaseBio Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).